3 April 2012
A revolutionary nasal spray could better remove fat which is clogging up arteries in the body, thus cutting the risk of people suffering from heart problems in later life.
The vaccine has already undergone tests which have resulted in positive results, which has led to the British Heart Foundation medical director Peter Weissberg calling the treatment "very promising".
In trials involving mice, the vaccine was found to reduce the amount of plaque in arteries by between 60 and 70 per cent.
This is because the treatment eased the body's immune system to better produce antibodies, which then fight against fatty deposits located in the arteries.
Researchers behind the unnamed vaccine are now working to get the medical product licensed, with the hope of introducing it to a worldwide market sometime in the next five years.
Scientists at the Scripps Translational Science Institute in San Diego have also looked to make a medical breakthrough recently by tracing a blood sample which could help doctors better calculate if a person is about to suffer a heart attack.
Posted by Jeanette Royston
Health News is provided by Adfero in collaboration with Spire Healthcare. Please note that all copy above is ©Adfero Ltd. and does not reflect views or opinions of Spire Healthcare unless explicitly stated. Additional comments on the page from individual Spire consultants do not necessarily reflect the views or opinions of other consultants or Spire Healthcare.